Paper8201224
Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period.
Stiehl A and 5 others. J Hepatol, 1994. Cited by 186 papers, by iCite.
Cite this record
ConductScience Library. Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period. Papers, record 8201224. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8201224
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cholangitis, Sclerosing | Major topic |
| Ursodeoxycholic Acid | Major topic |
| Adult | |
| Bile Acids and Salts | |
| Cholangiopancreatography, Endoscopic Retrograde | |
| Clinical Enzyme Tests | |
| Colitis, Ulcerative | |
| Double-Blind Method | |
| Humans | |
| Liver | |
| Liver Function Tests | |
| Pilot Projects | |
| Time Factors |
Source PubMed
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 186 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38862968 | Network proximity analysis as a theoretical model for identifying potential novel therapies in primary sclerosing cholangitis. | BMC Med Genomics | 2024 | https://conductscience.org/library/papers/38862968 | PubMed |
| 37007752 | Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology. | Prz Gastroenterol | 2023 | https://conductscience.org/library/papers/37007752 | PubMed |
| 35990218 | Review of pharmacotherapeutic treatments for primary sclerosing cholangitis. | Can Liver J | 2019 | https://conductscience.org/library/papers/35990218 | PubMed |
| 35359068 | [Guidelines on the diagnosis and management of primary sclerosing cholangitis (2021)]. | Zhonghua Gan Zang Bing Za Zhi | 2022 | https://conductscience.org/library/papers/35359068 | PubMed |
| 31762074 | Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease. | Aliment Pharmacol Ther | 2020 | https://conductscience.org/library/papers/31762074 | PubMed |
| 31154395 | British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. | Gut | 2019 | https://conductscience.org/library/papers/31154395 | PubMed |
| 29951926 | Clinical guidelines for primary sclerosing cholangitis 2017. | J Gastroenterol | 2018 | https://conductscience.org/library/papers/29951926 | PubMed |
| 29138587 | Primary sclerosing cholangitis: diagnostic and management challenges. | Clin Exp Gastroenterol | 2017 | https://conductscience.org/library/papers/29138587 | PubMed |
| 28417463 | Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28417463 | PubMed |
| 28381955 | Management Of Primary Sclerosing Cholangitis. | Gastroenterol Hepatol (N Y) | 2006 | https://conductscience.org/library/papers/28381955 | PubMed |
| 26770670 | A review of the medical treatment of primary sclerosing cholangitis in the 21st century. | Ther Adv Chronic Dis | 2016 | https://conductscience.org/library/papers/26770670 | PubMed |
| 26378046 | A network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis. | Oncotarget | 2015 | https://conductscience.org/library/papers/26378046 | PubMed |
| 25434314 | Overlap syndromes: an emerging diagnostic and therapeutic challenge. | Saudi J Gastroenterol | 2014 | https://conductscience.org/library/papers/25434314 | PubMed |
| 24529302 | Primary sclerosing cholangitis: diagnosis and treatment. | Dtsch Arztebl Int | 2013 | https://conductscience.org/library/papers/24529302 | PubMed |
| 23634279 | Treatment of autoimmune liver disease: current and future therapeutic options. | Ther Adv Chronic Dis | 2013 | https://conductscience.org/library/papers/23634279 | PubMed |
| 22228965 | Recurrence and rejection in liver transplantation for primary sclerosing cholangitis. | World J Gastroenterol | 2012 | https://conductscience.org/library/papers/22228965 | PubMed |
| 21656181 | In PSC with colitis treated with UDCA, most colonic carcinomas develop in the first years after the start of treatment. | Dig Dis Sci | 2011 | https://conductscience.org/library/papers/21656181 | PubMed |
| 21249655 | Bile acids for primary sclerosing cholangitis. | Cochrane Database Syst Rev | 2011 | https://conductscience.org/library/papers/21249655 | PubMed |
| 21180531 | Current status of therapy in autoimmune liver disease. | Ther Adv Gastroenterol | 2009 | https://conductscience.org/library/papers/21180531 | PubMed |
| 20127368 | Bezafibrate for the treatment of primary sclerosing cholangitis. | J Gastroenterol | 2010 | https://conductscience.org/library/papers/20127368 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GGT1 | 2678 | PubTator's text mining | https://conductscience.org/library/genes/2678 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8201224
GET https://conductscience.org/api/papers/v1/8201224/cited_by?page=2